On Wednesday, Fitterfly, a digital health and therapeutics, announced to raise fund $12 million in Series A, which was led by Amazon Smbhav Venture Fund and Fireside Ventures. Existing investors also included named 9 Unicorns, Venture Catalysts and Nihar Parikh, who is the Founder of Health Ventures, and Sriram Natarajan who is the Founder of Molbio.

To increase Diabefly’s reach, their digital therapeutics and clinically proven programme. Also, to prevent and manage reverse diabetes. This fund is also used to enhance the technology stack to give unique clinical insights to FitterFly

• Andhra Pradesh Approves Rs 500 Crore Port, Shipbuilding Cluster
• Amazon Eyes Faster Content Production With AI
• Why India Is Emerging as a Second Home for Multinationals
• Indigo Shares Slip 2% as CCI Orders Further Investigation 
• Concord Control Wins KAVACH 4.0 Order; Stock Jumps 4%

Dr Arbinder Singal, CEO and co-founder, of Fitterfly, said, “We want to take our clinically-proven diabetes and weight management system to the people who need it the most. This funding will help us strengthen our research, launch new verticals in the heart health space and grow our customer base by reaching out to people living with diabetes and the universe of doctors and organisations in the field of chronic disease management. Our corporate wellness models push the envelope from ‘tick-mark-based bundling’ to an ‘outcome-based approach’.”